Matsushita, Kunihiro http://orcid.org/0000-0002-7179-718X
Ballew, Shoshana H.
Wang, Angela Yee-Moon http://orcid.org/0000-0003-2508-7117
Kalyesubula, Robert
Schaeffner, Elke http://orcid.org/0000-0002-7925-4577
Agarwal, Rajiv
Article History
Accepted: 26 July 2022
First Online: 14 September 2022
Competing interests
: K.M. received support from NIDDK (R01DK100446) during the submitted work, personal fees and research funding from Kyowa Kirin, and personal fees from Akebia and Fukuda Denshi outside of the submitted work. R.A. reports personal fees and nonfinancial support from Bayer Healthcare Pharmaceuticals Inc., Akebia Therapeutics, Boehringer Ingelheim, Eli Lilly and Vifor Pharma; he has received personal fees from Lexicon and Reata; he is a member of data safety monitoring committees for Vertex and Chinook; a member of steering committees of randomized trials for Akebia Therapeutics, Bayer, and Relypsa; and a member of adjudication committees for Bayer; he has served as associate editor of the <i>American Journal of Nephrology</i> and <i>Nephrology Dialysis Transplantation</i> and has been an author for <i>UpToDate</i>; and he has received research grants from the US NIH and US Veterans Affairs. The other authors declare no competing interests.